Trident Lifeline Ltd (543616) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543616 | NSE: | Pharmaceuticals & Drugs | Small Cap

Trident Lifeline Share Price

305 0.00 0.00%
as on 05-Dec'25 12:09

Trident Lifeline Ltd (543616) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543616 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Trident Lifeline

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Trident Lifeline stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
27.21
Market Cap:
355.1 Cr.
52-wk low:
222
52-wk high:
325

Is Trident Lifeline Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Trident Lifeline: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Trident Lifeline Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -9.1%33.7%55.1%25.1%19.1%27.7%-
Value Creation
Index
NA1.42.90.80.41.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 4.99.621.831.744.767.868
Sales YoY Gr.-95.1%126.3%45.6%40.9%51.9%-
Adj EPS -2.61.24.95.1611.111.2
YoY Gr.-NA314.5%5.2%18.2%84.6%-
BVPS (₹) -9.7-0.9639.745.857.166.9
Adj Net
Profit
-0.80.63.95.96.912.813
Cash Flow from Ops. -0.61.5-0.2-16.60.9-3.5-
Debt/CF from Ops. -10.93.1-12.8-0.26.9-4.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA68.9%46%51.9%
Adj EPS NANA31.9%84.6%
BVPSNANA112.3%24.8%
Share Price - - 34.6% 8.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
27.1-33.6180.323.314.121.618.1
Op. Profit
Mgn %
-5.51312.419.819.926.125.3
Net Profit
Mgn %
-16.56.117.818.515.518.919.3
Debt to
Equity
-2.2-9.60.50.10.10.20.1
Working Cap
Days
022316426735532678
Cash Conv.
Cycle
030339511810246

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Trident Lifeline Ltd.

Standalone Consolidated
TTM EPS (₹) 11.2 10.1
TTM Sales (₹ Cr.) 67.8 87
BVPS (₹.) 66.9 63.3
Reserves (₹ Cr.) 66 65
P/BV 4.56 4.82
PE 27.21 30.23
From the Market
52 Week Low / High (₹) 222.00 / 324.95
All Time Low / High (₹) 102.75 / 339.00
Market Cap (₹ Cr.) 355
Equity (₹ Cr.) 11.6
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Trident Lifeline:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.001.760.000.003.463.463.463.43
* Pledged shares as % of Promoter's holding (%)

Valuation of Trident Lifeline - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Trident Lifeline

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales51022324568
Operating Expenses 5819253650
Manufacturing Costs0155613
Material Costs3611162528
Employee Cost 111123
Other Costs 113337
Operating Profit -0136918
Operating Profit Margin (%) -5.5%13.0%12.4%19.8%19.9%26.1%
Other Income 001123
Interest 100011
Depreciation 000012
Exceptional Items 000000
Profit Before Tax -11371018
Tax -00-1135
Profit After Tax -1146713
PAT Margin (%) -16.1%6.6%18.1%19.0%15.8%19.3%
Adjusted EPS (₹)-2.61.34.95.26.111.4
Dividend Payout Ratio (%)0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund -3-05465366
Share Capital 358111111
Reserves -6-5-3344154
Minority Interest000000
Debt6523614
Long Term Debt651046
Short Term Debt001328
Trade Payables2455810
Others Liabilities -1213810
Total Liabilities 41013567499

Fixed Assets

Gross Block12241018
Accumulated Depreciation011123
Net Fixed Assets 1113815
CWIP 000041
Investments 0004412
Inventories15471117
Trade Receivables115121420
Cash Equivalents 0001462
Others Assets 123162733
Total Assets 41013567499

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -11-0-171-3
PBT -11371018
Adjustment 1100-11
Changes in Working Capital -00-4-23-6-18
Tax Paid 000-1-2-4
Cash Flow From Investing Activity -0-1-0-6-11-8
Capex -0-1-0-2-9-5
Net Investments 00-0-4-0-8
Others 0001-25
Cash Flow From Financing Activity 1-113627
Net Proceeds from Shares 1233500
Net Proceeds from Borrowing 0-2-3-133
Interest Paid -1-0-0-0-0-1
Dividend Paid 000000
Others 0-112-05
Net Cash Flow 0-0014-8-4

Finance Ratio

PARTICULARSMar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)N/AN/A183.423.8714.3422.05
ROCE (%)N/AN/A55.1125.119.1127.66
Asset Turnover Ratio1.141.381.940.920.690.78
PAT to CFO Conversion(x)N/A1-0-2.830.14-0.23
Working Capital Days
Receivable Days9737479910692
Inventory Days6911875637574
Payable Days20219415711290114

Trident Lifeline Ltd Stock News

Trident Lifeline Ltd FAQs

The current trading price of Trident Lifeline on 05-Dec-2025 12:09 is ₹305.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Trident Lifeline stood at ₹355.1.
The latest P/E ratio of Trident Lifeline as of 04-Dec-2025 is 27.21.
The latest P/B ratio of Trident Lifeline as of 04-Dec-2025 is 4.56.
The 52-week high of Trident Lifeline is ₹324.9 and the 52-week low is ₹222.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Trident Lifeline is ₹67.80 ( Cr.) .

About Trident Lifeline Ltd

The Company was originally incorporated as “Trident Lifeline Private Limited” as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated January 09, 2014, issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently, the Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of the Company held on June 02, 2022 and the name of the Company was changed to “Trident Lifeline Limited”. A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated June 10, 2022 was issued by the Registrar of Companies, Ahmedabad.

Trident Lifeline is engaged in the pharmaceutical business ethical marketing in domestic as well as international market. It is also engaged in distribution of pharmaceutical products through third party distribution network. It offers wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan lisence. It operates in India as well as African, Latin American and East Indian Countries. It has its presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venuzela.

The company is engaged in the business of marketing pharmaceutical products. For which it has obtain necessary approvals from FDA for getting the formulations manufacture from contract manufacturers on Loan License or on principle-to-principle basis. It also takes the necessary Trademark approvals & registrations wherever required. Its Pharma business operations are supported by various contract manufacturers having facilities which are approved by FDA/WHO and other relevant authorities. It typically works on contract manufacturing basis or at times purchase order basis, depending upon customer’s requirement, with manufacturer of pharma products. Presently the company operates with one contract manufacturer. The company has maintained relationship with the regular supplier, having FDA and WHO approved plant to supply pharma formulations. These units manufacture tablets, capsules, dry powder, syrup under its own brands.

Business area of the company

The company is engaged in the manufacturing and marketing of quality finished dosages. It is one of the fastest growing pharmaceutical companies in the SME segment providing unprecedented quality of healthcare products. It deals in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. Its product portfolio comprises of vide range of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steriodal anti-inflamatory drug (NSAIDS).

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×